Publications by authors named "Daniela Risco-Acevedo"
Article Synopsis
- The pandemic spread of SARS-CoV-2 has challenged the scientific community due to the virus's ability to inhibit the body's natural immune response, specifically the interferon response.
- Recombinant interferons, historically effective in treating viral diseases and certain cancers, were initially deployed in China as a treatment and preventive measure for COVID-19, sparking interest among clinicians.
- The review highlights the mechanism of interferons, their interaction with receptors, how coronaviruses disrupt this signaling, and discusses the significance of genes like ACE2, while advocating for the timely use of interferons in COVID-19 treatment.
